7 September 2016, London, UK: The Life Sciences practice at Instinctif Partners, the business communications consultancy, congratulates its clients Clinigen Group plc (‘Clinigen’) and Immunocore for winning awards at the Biotech and Money Gala Dinner.
Voting and presentation of the awards was held in London on Tuesday, 6 September 2016. The event, which celebrated the UK Life Sciences sectors funding, finance and investment successes over the last 12 months took place at London’s Gibson Hall with leading lights and emerging stars, C-suite executives, sector investors and influencers in attendance.
Clinigen won the “Public UK Life Science Company of the Year” award and Immunocore won the “Private UK Life Science Company of the Year” award with Dr Eliot Forster being awarded the “UK Life Science CEO of the year” award.
Instinctif Partners is a member of the Biotech and Money Advisory Board and Managing Partner, Sue Charles took part in the 2016 Awards executive judging panel.
“All of those shortlisted deserve acknowledgment in these awards” said Sue Charles, Managing Partner of Instinctif Partners’ Life Sciences practice. “The UK Life Sciences sector had an incredibly strong year last year and these awards are a great way to recognise that success. We are especially pleased for Clinigen and Immunocore, their awards acknowledged their progress and their contribution to the sector over the last twelve months” she added.
Instinctif Partners’ clients Abcam, Abzena, Autifony, Auspherix, Karus Therapeutics, Novabiotics and Puridify were also shortlisted for awards. To see the full list of finalists and winners, click here.
Instinctif Partners is a leading international business communications consultancy and has recently been named the 2016 PRCA City Agency of the Year. Instinctif Partners has an exceptionally strong team focused in the Life Sciences sector. This Life Sciences team has expertise across financial, corporate, healthcare and marketing communications, and integrates design and digital into its communications mix. Offering global outreach, its client base spans pharma, biotechnology, medical devices, diagnostics, healthcare, laboratory supply and service providers in addition to venture capitalists, recruitment companies, not-for-profit, academic organisations and science-associated bodies.